Detalles de la búsqueda
1.
Carbon sources and pathways for citrate secreted by human prostate cancer cells determined by NMR tracing and metabolic modeling.
Proc Natl Acad Sci U S A
; 119(14): e2024357119, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353621
2.
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
Crit Rev Clin Lab Sci
; : 1-27, 2023 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882463
3.
The gaps between the new EU legislation on in vitro diagnostics and the on-the-ground reality.
Clin Chem Lab Med
; 61(2): 224-233, 2023 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409605
4.
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 24(10)2023 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240349
5.
Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptides.
Prostate
; 82(6): 657-665, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35098567
6.
Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Br J Cancer
; 126(6): 907-916, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34912074
7.
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Int J Cancer
; 148(2): 385-395, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32965028
8.
The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers.
Int J Mol Sci
; 22(4)2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567533
9.
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
Int J Cancer
; 146(11): 3196-3206, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31745978
10.
Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population.
Prostate
; 80(6): 500-507, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32077525
11.
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Clin Chem
; 66(6): 842-851, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32408351
12.
Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-13 C]pyruvate MRS and [18 F]FDG-PET.
NMR Biomed
; 33(10): e4362, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32662543
13.
Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy.
J Urol
; 202(2): 256-263, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31026217
14.
A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
BJU Int
; 124(4): 609-620, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31106513
15.
The importance of targeting intracrinology in prostate cancer management.
World J Urol
; 37(5): 751-757, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30350016
16.
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports.
BMC Urol
; 19(1): 124, 2019 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31783839
17.
Consensus on molecular imaging and theranostics in prostate cancer.
Lancet Oncol
; 19(12): e696-e708, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30507436
18.
Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients.
Prostate
; 78(5): 336-342, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29330943
19.
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate Cancer.
Ther Drug Monit
; 40(2): 222-229, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29419723
20.
A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
Prostate
; 77(14): 1401-1407, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28853167